Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhen Xun

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Cellular & Molecular Immunology|January 12, 2021
Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8<sup>+</sup> T and NK cell functionZhen Xun, Jinpiao Lin, Qingqing Yu, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 24, 2020
IL-17 and IL-21 polymorphisms in relation to HBV related hepatocellular carcinoma in Chinese Han populationWennan Wu, Yongbin Zeng, Jinpiao Lin, et al.
Frontiers in Immunology|July 18, 2024
Monocyte distribution width as a promising biomarker for differential diagnosis of chronic hepatitis, cirrhosis, and hepatocellular carcinomaSheng Lin, Xinyao Yang, Xin Yang, et al.
JHEP Reports : Innovation in Hepatology|July 23, 2025
A novel therapy targeting the gut-liver axis for chronic hepatitis B: Ursodeoxycholic acid plus <i>Bifidobacterium</i>Zhen Xun, Xiaobao Yao, Caorui Lin, et al.
Journal of Hepatology|July 11, 2024
Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis BJian-Wei Zhang, Rui-Min Lai, Long-Fei Wang, et al.
Cellular & Molecular Immunology|September 23, 2020
The innate immune effector ISG12a promotes cancer immunity by suppressing the canonical Wnt/β-catenin signaling pathwayRilin Deng, Chaohui Zuo, Yongqi Li, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Cellular & Molecular Immunology|January 12, 2021
Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8<sup>+</sup> T and NK cell functionZhen Xun, Jinpiao Lin, Qingqing Yu, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 24, 2020
IL-17 and IL-21 polymorphisms in relation to HBV related hepatocellular carcinoma in Chinese Han populationWennan Wu, Yongbin Zeng, Jinpiao Lin, et al.
Frontiers in Immunology|July 18, 2024
Monocyte distribution width as a promising biomarker for differential diagnosis of chronic hepatitis, cirrhosis, and hepatocellular carcinomaSheng Lin, Xinyao Yang, Xin Yang, et al.
JHEP Reports : Innovation in Hepatology|July 23, 2025
A novel therapy targeting the gut-liver axis for chronic hepatitis B: Ursodeoxycholic acid plus <i>Bifidobacterium</i>Zhen Xun, Xiaobao Yao, Caorui Lin, et al.
Journal of Hepatology|July 11, 2024
Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis BJian-Wei Zhang, Rui-Min Lai, Long-Fei Wang, et al.
Cellular & Molecular Immunology|September 23, 2020
The innate immune effector ISG12a promotes cancer immunity by suppressing the canonical Wnt/β-catenin signaling pathwayRilin Deng, Chaohui Zuo, Yongqi Li, et al.
Pageof 6